PTX

2.44%

4.2¢ prescient therapeutics limited

What you you think about the prospects of the Q4/Q1 pre-clinical...

First 552 Last

Share
Profile

Follow
supernologic

127 Posts.

72

24/09/21

15:03

Post #: 56328794
Share

Originally posted by threebeez: ↑

I agree that BD has made many great contributions along with others, in the finer detail they have found and shared.
For that, BD and others have a following that seem to rely on their opinions. I form my own opinions from a wider sources.
While I appreciate the detail given freely I may come to different conclusions as to what is meant or said - especially what it may mean for the future.

While yourself and others consider PTX is in a SP rerate/transformation after a consolidation phase I only expect it when the next round of PTX 100/200 trials are showing favorable results. If the rerate/transformation occurs sooner as you expect I will not be upset - but I will wait for the real results to buy more for I already hold plenty to profit from.
I hold a wider view that the globalized market is at a risky point with major debt, deficit and inflation problems so that if something goes awry the PTX SP will suffer along with the rest and I will be prepared to fold some but not PTX if something bad occurs. I do my best to buy the dips as well as when fundamentals are imminent, but like many I have failures trying

I have no conflict with any of your comments or opinions about trading for I am not one. I do not understand FUD. I do see the SP rising and falling with the general market from time to time as well as before and after some news. I assume that is the trading you refer to.

I believe all PTX holders will make good money if they hold long enough - years at least - a decade preferably.

Expand

What you you think about the prospects of the Q4/Q1 pre-clinical work adding some strong support to the share price then?

We have all seen the potential of Car-T in blood cancers, but if they can get some indications of efficacy against solid tumours and dealing with TME problems, with something that has an on-off switch, that can target multiple antigens, and can be monitored then what?? It's not just going to be a couple of mice getting excited to live another day I would think.

PTX Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GRX

GreenX picks up prospective copper project in Germany

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

WGX

Westgold sets its sights on top five producer status through merger with Karora

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Is oil undervalued?

There are more pages in this discussion • 289 more messages in this thread...

First 552 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 4.2¢		Change 0.001(2.44%)		Mkt cap ! $33.82M

Open	High	Low	Value	Volume
4.1¢	4.3¢	4.1¢	$27.29K	650.9K

Buyers (Bids)

No.	Vol.	Price($)
2	74314	4.1¢

Sellers (Offers)

Price($)	Vol.	No.
4.3¢	57451	1

View Market Depth

No.	Vol.	Price($)
1	20000	0.041
7	820840	0.040
6	547589	0.039
3	86160	0.038
4	470000	0.037

Price($)	Vol.	No.
0.043	57451	1
0.044	500000	1
0.045	868286	7
0.046	13200	1
0.047	525000	2

Last trade - 16.10pm 02/08/2024 (20 minute delay)

PTX (ASX) Chart

What you you think about the prospects of the Q4/Q1 pre-clinical...

Venture to sniff out high-grade REE targets at Jupiter project, WA

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GreenX picks up prospective copper project in Germany

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

What you you think about the prospects of the Q4/Q1 pre-clinical...

Top Stories

Venture to sniff out high-grade REE targets at Jupiter project, WA

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

GreenX picks up prospective copper project in Germany

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Westgold sets its sights on top five producer status through merger with Karora

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News